Completed
Comera Life Sciences
First | 2020-12-21 | $9.95 | |
Merger | 2022-05-20 | $8.85 | 11% |
Merger +6mo | 2022-11-21 | $1.28 | 87% |
Merger +1yr | 2023-05-22 | $0.65 | 93% |
Recent | 2024-06-03 | $0.02 | 100% |
OTR Acquisition Corp.
- Registration2020-08-17 Filed S1
- IPO2020-11-19 IPO, search begins
- Definitive Agreement2022-01-31 Agreement for merger
- Completed2022-05-19 Merger Completed
- Raised
- $115M
- CIK
- 1821318
- SPAC Ticker
- OTRAU
- Merger
- Comera Life Sciences
- Merged Ticker
- CMRA
- Focus
- Unicorns
SPAC Team
Leadership
Nicholas J. Singer, our Chief Executive Officer, Chief Financial Officer and Chairman has over 20 years of experience in finance and investment. Nicholas J. Singer is the Founder of Purchase Capital, an investment firm that serves as Mr. Singer’s family office and sponsor to leading institutional investors and third-party family offices. Since Mr. Singer becoming Managing Member in 2013, Purchase Capital provides patient capital for private and public companies that have significant potential for long-term value creation. He is also the Founder & Executive Chairman of United Parks, the Executive Chairman of IntegriCo Composites, a Board Member of Brooklyn ImmunoTherapeutics, and a Trustee of the Pérez Art Museum Miami. From 2007 to 2013, Mr. Singer was the Co-Founder & Co-Managing Member of Standard General, an SEC registered investment advisor which managed over $1 billion of assets during his tenure. Prior to that, he was a Founding Partner of Cyrus Capital Partners, a Principal at Och-Ziff Capital Management, and an analyst in High Yield Trading and in the Principal Investment Area at Goldman Sachs & Co. He graduated summa cum laude with a B.S. in Economics from the Wharton School and a B.A.S. in Electrical Engineering from the School of Engineering and Applied Science at the University of Pennsylvania.